In addition to these roles, survivin regulates signal transduction pathways associated with cancer.11 While suggested as a therapeutic target,12 drugging survivin or related IAPs has yet to reach fruition, and presents a drug discovery challenge we felt our strategy would be particularly suited to facilitate.13 Here, we develop an agnostic method to identify fluorescent ligands to survivin. This evidence concerns the gene BIRC5 and cancer.